No insider purchase over the last 90 days. The latest, by 김용관, was filed 09 Feb 2026.
JW Shinyak Corporation: what insiders have been doing
JW Shinyak Corporation belongs to the Health Care sector. Filings by its managers are published through DART (FSS). In the past year (31 October 2025 to 31 October 2026), 4 filings came from 3 insiders.
Every open-market trade in the period is a purchase: 3 purchases, from 2 insiders, and not a single sale. No amount is published for 3 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 chief executive among the declarants.
The last purchase on record was published on 9 February 2026, which is 272 days ago.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 4 filings, this issuer sits below that mark. Since 2021, the database holds 20 purchases and no sales by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- +10.6%Entry ₩2,080 · Close 29 Oct 2026 ₩2,300
- +10.6%Entry ₩2,080 · Close 29 Oct 2026 ₩2,300
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ●Executives0DART
- 551 sharesShareKRXDART:20260209000353Canonical exit: 10 May 2026 (T+90)
- 820,389 sharesKRXDART:20260209000321Canonical exit: 2 Apr 2026 (T+90)
- 819,838 sharesShareKRXDART:20260209000339Canonical exit: 10 May 2026 (T+90)
- 648 sharesShareKRXDART:20250207000698Canonical exit: 8 May 2025 (T+90)
- 525 sharesShareKRXDART:20250207000691Canonical exit: 8 May 2025 (T+90)
- 780,798 sharesShareKRXDART:20250207000664Canonical exit: 8 May 2025 (T+90)
- 781,323 sharesKRXDART:20250207000653Canonical exit: 1 Apr 2025 (T+90)
- 500 sharesShareKRXDART:20240207000863Canonical exit: 31 Mar 2024 (T+90)
- 50 sharesShareKRXDART:20240207000871Canonical exit: 31 Mar 2024 (T+90)
- 744,167 sharesKRXDART:20240207000834Canonical exit: 31 Mar 2024 (T+90)
- 743,617 sharesShareKRXDART:20240207000856Canonical exit: 31 Mar 2024 (T+90)
- ShareKRXDART:20230901000119Canonical exit: 29 Nov 2023 (T+90)
- 781,323 sharesKRXDART:20230901000118Canonical exit: 27 Nov 2023 (T+90)
- ShareKRXDART:20230823000172Canonical exit: 20 Nov 2023 (T+90)
- 781,323 sharesKRXDART:20230823000164Canonical exit: 16 Nov 2023 (T+90)
- ●Executives0DART
- 708,206 sharesKRXDART:20230209000545Canonical exit: 10 May 2023 (T+90)
- 708,206 sharesShareKRXDART:20230209000593Canonical exit: 1 Apr 2023 (T+90)
- ShareKRXDART:20220429001243Canonical exit: 28 Jul 2022 (T+90)
- ShareKRXDART:20220429001260Canonical exit: 28 Jul 2022 (T+90)
- 781,323 sharesKRXDART:20220429001219Canonical exit: 28 Jul 2022 (T+90)
- ●Executives0DART
- ●Executives0DART
24 of 24 declarations
About JW Shinyak Corporation
JW신약 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative drugs and therapeutic solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
